Back to Search Start Over

Eleclazine, a new selective cardiac late sodium current inhibitor, confers concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in an intact porcine model.

Authors :
Fuller, Henrique
Justo, Fernanda
Nearing, Bruce D.
Kahlig, Kristopher M.
Rajamani, Sridharan
Belardinelli, Luiz
Verrier, Richard L.
Source :
Heart Rhythm; Aug2016, Vol. 13 Issue 8, p1679-1686, 8p
Publication Year :
2016

Abstract

<bold>Background: </bold>The cardiac late sodium current (INa) has been increasingly implicated in the initiation of atrial fibrillation (AF). Eleclazine (formerly known as GS-6615) is a new selective late INa inhibitor and is undergoing clinical testing for the treatment of cardiac arrhythmias.<bold>Objective: </bold>We tested whether late INa inhibition by eleclazine confers protection against atrial premature beats (APBs) and AF.<bold>Methods: </bold>In closed-chest anesthetized Yorkshire pigs, epinephrine (2.0 µg/kg, intravenous, bolus over 1 minute) was administered alone to induce APBs (n = 6) or in combination with intrapericardial acetylcholine (0.5-4 mL of 12.5 mM solution) to induce spontaneous AF (n = 11). Effects of eleclazine (0.3 and 0.9 mg/kg, intravenous, over 15 minutes) on APBs and AF were determined.<bold>Results: </bold>Epinephrine-induced APBs were reduced >3-fold (P < .04) after eleclazine (0.9 mg/kg) infusion. The combined administration of epinephrine and acetylcholine resulted in AF in all animals tested, which was invariably preceded by APBs. Eleclazine pretreatment suppressed AF in all 7 animals in at least 1 test episode during the 60- to 150-minute observation period (P = .04). The plasma eleclazine level at 120 minutes was 828 ± 45.8 nM, within exposure range evaluated clinically. Eleclazine shortened ventricular QT and atrial PTa intervals by 7% (P < .001 for both) and reduced atrial repolarization alternans (P = .003) and heterogeneity (P = .021) without attenuation of the inotropic response to catecholamine (P = .56). The drug inhibited the enhanced late INa of single atrial myocytes with a potency of 736 ± 67 nM.<bold>Conclusion: </bold>Selective cardiac late INa inhibition with eleclazine suppresses autonomically mediated atrial repolarization alternans and heterogeneity, APBs, and AF in an intact porcine model. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15475271
Volume :
13
Issue :
8
Database :
Supplemental Index
Journal :
Heart Rhythm
Publication Type :
Academic Journal
Accession number :
116963038
Full Text :
https://doi.org/10.1016/j.hrthm.2016.04.015